Acquisition Completes and Establishes Key Revenue Drivers
Lipella Pharmaceuticals,
PRISM MarketView,
Biotech,
Healthcare,
PRISM DigitalMedia,
Pharmaceutical,
PRISM MediaWire,
NASDAQ,
LIPO,
Public Health
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
-Lipella Granted Two Orphan Drug Designations by FDA-
BioStem,
PRISM MarketView,
OTC Markets,
Biotech,
OTC,
Stock Market,
Wound Care,
Healthcare,
PRISM DigitalMedia,
PRISM MediaWire
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT
Premier Press Release Services
Newswire Reimagined: Reach more investors, media and customers with precision targeting.